landmark NIH hypertension study will change how patients with high blood pressure are treated

New results from the landmark NIH hypertension study will change how patients with high blood pressure are treated.

Currently, most hypertension patients start on an ACE inhibitor, beta-blocker, or calcium channel blocker.

A thiazide diuretic is often added when extra blood pressure control is needed.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote